|
Quotes & Info
|
| LH > SEC Filings for LH > Form 8-K on 2-Mar-2009 | All Recent SEC Filings |
2-Mar-2009
Regulation FD Disclosure
On March 2, 2009, Laboratory Corporation of America® Holdings (LabCorp®) (NYSE:
LH) announced the appointment of Dr. Mark Elliott Brecher as Chief Medical
Officer.
Dr. Brecher is a leader in the field of pathology, with research published in a wide variety of journals including the New England Journal of Medicine, The Lancet and the Mayo Clinic Proceedings. Prior to joining LabCorp, Dr. Brecher served as Vice Chair of the Department of Pathology and Laboratory Medicine at the McLendon Clinical Laboratories, University of North Carolina Hospitals.
Exhibits
99.1 Press Release dated March 2, 2009
|
|